This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of British Columbia directory, so their courses and email address may be missing. Find their university profile.
Research
Latest papers
Immunogenicity and safety of a third and subsequent COVID-19 vaccine doses in patients with plasma cell dyscrasias
Blood advances · 2026
Latest funding
- $2,000,000
Allogeneic regulatory T cell therapy to prevent graft versus host disease
CIHR · 2024 · Co-investigator
- $20,000
Allogeneic regulatory T cell therapy to prevent chronic graft versus host disease
CIHR · 2023 · Principal investigator
- $3,051,528
A Phase I trial of single domain antibody-based CD22 chimeric antigen receptor (CAR)-T cells for the treatment of relapsed/refractory CD22+ B-cell acute lymphoblastic leukemia
CIHR · 2022 · Principal investigator
1 publications.
Immunogenicity and safety of a third and subsequent COVID-19 vaccine doses in patients with plasma cell dyscrasias
Bhella S, Agbayani G, Hueniken K, Vijenthira A, Wilkin AM, Sebag M, Wang P, Hicks LK, Hay AE, Hosseini-Moghaddam SM
Allogeneic regulatory T cell therapy to prevent graft versus host disease
Principal investigators: Levings, Megan K; Schultz, Kirk R; Ahmad, Imran; Dijke, Ilona E; Hay, Kevin A; Lad, Deepesh P; West, Lori J
Keywords: Cell Therapy; Graft Versus Host Disease; Regulatory T Cells; Tolerance; Transplantation
Allogeneic regulatory T cell therapy to prevent chronic graft versus host disease
Principal investigators: Levings, Megan K; Delisle, Jean-Sébastien; Ahmad, Imran; Dijke, Ilona E; Elsawy, Mahmoud E; Hay, Kevin A; Kekre, Natasha; Szwajcer, David; West, Lori J
Keywords: Cell Therapy; Graft Versus Host Disease; Regulatory T Cells; Tolerance; Transplantation
A Phase I trial of single domain antibody-based CD22 chimeric antigen receptor (CAR)-T cells for the treatment of relapsed/refractory CD22+ B-cell acute lymphoblastic leukemia
Principal investigators: Hay, Kevin A; Hawrysh, Terry A; Kekre, Natasha; Krueger, Joerg; Li, Amanda; Szwajcer, David
Keywords: Adoptive Immunotherapy; B-Cell Acute Lymphoblastic Leukemia; Cd22; Chimeric Antigen Receptor T Cells (Car-T)
A Phase I trial of single domain antibody-based CD22 chimeric antigen receptor (CAR)-T cells for the treatment of relapsed/refractory CD22+ B-cell acute lymphoblastic leukemia
Principal investigators: Hay, Kevin A; Hawrysh, Terry A; Kekre, Natasha; Krueger, Joerg; Li, Amanda; Szwajcer, David
Keywords: Adoptive Immunotherapy; B-Cell Acute Lymphoblastic Leukemia; Cd22; Chimeric Antigen Receptor T Cells (Car-T)
A Phase I first-in-human trial of CLIC-2201, a VHH-CD22 CAR-T cell product for the treatment of relapsed/refractory CD22 positive B-cell non-Hodgkin lymphoma
Principal investigators: Hay, Kevin A; Kekre, Natasha
Keywords: Adoptive Immunotherapy; Car-T Cells; Chimeric Antigen Receptor; Diffuse Large B-Cell Lymphoma (Dlbl); Non-Hodgkin'S Lymphoma; Phase I Clinical Trial
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Department of Medicine
- Medicine
- Surgery
- Oncology
- Infectious Diseases
- Department of Surgery
- Epidemiology Division
- Other
Co-authors at University of British Columbia, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
Natasha Kekre
Department of Medicine
1 shared papers, latest 2026
Christopher Bredeson
Faculty
1 shared papers, latest 2026
Tara Baetz
Faculty
1 shared papers, latest 2026
Natasha Kekre
Medicine
1 shared papers, latest 2026
Shelly Bolotin
Epidemiology Division
1 shared papers, latest 2026
Arleigh McCurdy
Department of Medicine
1 shared papers, latest 2026
David Allan
Department of Medicine
1 shared papers, latest 2026
Stephen Betschel
Department of Medicine
1 shared papers, latest 2026
Michael Chu
Department of Surgery
1 shared papers, latest 2026
Amaris Karin Balitsky
Oncology
1 shared papers, latest 2026
Michael Sebag
Medicine
1 shared papers, latest 2026
Curtis Cooper
Department of Medicine
1 shared papers, latest 2026
Shelly Bolotin
Pediatrics
1 shared papers, latest 2026
Donna Reece
Faculty
1 shared papers, latest 2026
Shelly Bolotin
Faculty
1 shared papers, latest 2026
Matthew Cheung
Faculty
1 shared papers, latest 2026
Deepali Kumar
Infectious Diseases
1 shared papers, latest 2026
James Brooks
Faculty
1 shared papers, latest 2026
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.